Sanofi Consumer Healthcare India Ltd.
National Stock Exchange of IndiaTotal Valuation
Sanofi Consumer Healthcare India Ltd. carries a market capitalization of 105.98B, placing it among publicly traded companies globally. Its enterprise value stands at 98.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 105.98B |
| Enterprise Value | 98.89B |
Valuation Ratios
Sanofi Consumer Healthcare India Ltd. trades at a trailing price-to-earnings ratio of 38.35.
| PE Ratio | 38.35 |
| PS Ratio | 10.58 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Sanofi Consumer Healthcare India Ltd. trades at an EV/EBITDA multiple of 30.82 and an EV/FCF ratio of 6,285.10. The EV/Sales ratio of 10.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.82 provides insight into valuation relative to core operating earnings.
| EV / Sales | 10.58 |
| EV / EBITDA | 30.82 |
| EV / EBIT | 30.82 |
| EV / FCF | 6,285.10 |
Financial Position
Sanofi Consumer Healthcare India Ltd. maintains a current ratio of 6.60, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.47, indicating elevated leverage, while an interest coverage ratio of 152.81 demonstrates strong ability to service its debt obligations.
| Current Ratio | 6.60 |
| Quick Ratio | 4.56 |
| Debt / Equity | 17.47 |
| Debt / EBITDA | N/A |
| Interest Coverage | 152.81 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1,314.34 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Sanofi Consumer Healthcare India Ltd. has paid 863.00M in income taxes, reflecting an effective tax rate of 25.07.
| Income Tax | 863.00M |
| Effective Tax Rate | 25.07 |
Stock Price Statistics
Sanofi Consumer Healthcare India Ltd.'s stock has declined approximately -14.36308% over the past 52 weeks. The 50-day moving average sits at 4,698.31, while the 200-day moving average is 4,541.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.36308% |
| 50-Day Moving Average | 4,698.31 |
| 200-Day Moving Average | 4,541.28 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Sanofi Consumer Healthcare India Ltd. generated 9.35B in revenue and converted that into 2.58B in net income, yielding earnings per share of 111.98. EBITDA reached 3.21B, while operating income came in at 3.21B.
| Revenue | 9.35B |
| Gross Profit | 6.88B |
| Operating Income | 3.21B |
| Pretax Income | 3.44B |
| Net Income | 2.58B |
| EBITDA | 3.21B |
| EBIT | 3.21B |
| Earnings Per Share (EPS) | 111.98 |
Margins
Sanofi Consumer Healthcare India Ltd. operates with a gross margin of 73.53, reflecting its pricing power and cost economics. The operating margin of 34.32 and net profit margin of 27.58 provide insight into operational efficiency.
| Gross Margin | 73.53 |
| Operating Margin | 34.32 |
| Pretax Margin | 36.81 |
| Profit Margin | 27.58 |
| EBITDA Margin | 34.32 |
Scores
Sanofi Consumer Healthcare India Ltd. posts an Altman Z-Score of 94.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 94.64 |